Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Diagnostic Microbiology and Infectious Disease
|
May 16, 2017
Multicenter evaluation of the RAPIDEC® CARBA NP test for rapid screening of carbapenemase-producing Enterobacteriaceae and Gram-negative nonfermenters from clinical specimens
Marco Coppi, Alberto Antonelli, Tommaso Giani, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 23, 2022
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol-An All-Inclusive Guide for Clinicians
Luigi Principe, Tommaso Lupia, Lilia Andriani, et al.
Frontiers in Medicine
|
May 8, 2026
Multidistrict invasive <i>Candida glabrata</i> infection successfully treated with echinocandin and liposomal amphotericin B combination therapy: a case report and therapeutic perspective
Massimo Caracciolo, Francesco D'Aleo, Maria Francesca Stagno, et al.
Antibiotics (Basel, Switzerland)
|
April 23, 2022
Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. <i>Antibiotics</i> 2021, <i>10</i>, 1341
Gianluca Morroni, Raffaela Bressan, Simona Fioriti, et al.
Pharmaceuticals (Basel, Switzerland)
|
September 28, 2023
New Antimicrobials for Gram-Positive Sustained Infections: A Comprehensive Guide for Clinicians
Davide Carcione, Jari Intra, Lilia Andriani, et al.
Antibiotics (Basel, Switzerland)
|
November 27, 2021
Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections
Gianluca Morroni, Raffaela Bressan, Simona Fioriti, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 8, 2025
Fluoroquinolones and Biofilm: A Narrative Review
Nicholas Geremia, Federico Giovagnorio, Agnese Colpani, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|
February 14, 2025
Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based study
Salvatore Rotundo, Salvatore Nisticò, Helen Linda Morrone, et al.
International Journal of Antimicrobial Agents
|
May 19, 2021
Zidovudine in synergistic combination with fosfomycin: an in vitro and in vivo evaluation against multidrug-resistant Enterobacterales
Roberta Maria Antonello, Stefano Di Bella, Jonathan Betts, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 27, 2026
Cefepime and New Cefepime/Beta-Lactamase Inhibitor Combination for the Treatment of Gram-Negative Bacteria: Chemical Structure and Mechanism of Action, Microbiological Target, Clinical Use and PK/PD Characteristics
Davide Carcione, Gioconda Brigante, Antonella Carducci, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Diagnostic Microbiology and Infectious Disease
|
May 16, 2017
Multicenter evaluation of the RAPIDEC® CARBA NP test for rapid screening of carbapenemase-producing Enterobacteriaceae and Gram-negative nonfermenters from clinical specimens
Marco Coppi, Alberto Antonelli, Tommaso Giani, et al.
Pharmaceuticals (Basel, Switzerland)
|
April 23, 2022
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol-An All-Inclusive Guide for Clinicians
Luigi Principe, Tommaso Lupia, Lilia Andriani, et al.
Frontiers in Medicine
|
May 8, 2026
Multidistrict invasive <i>Candida glabrata</i> infection successfully treated with echinocandin and liposomal amphotericin B combination therapy: a case report and therapeutic perspective
Massimo Caracciolo, Francesco D'Aleo, Maria Francesca Stagno, et al.
Antibiotics (Basel, Switzerland)
|
April 23, 2022
Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. <i>Antibiotics</i> 2021, <i>10</i>, 1341
Gianluca Morroni, Raffaela Bressan, Simona Fioriti, et al.
Pharmaceuticals (Basel, Switzerland)
|
September 28, 2023
New Antimicrobials for Gram-Positive Sustained Infections: A Comprehensive Guide for Clinicians
Davide Carcione, Jari Intra, Lilia Andriani, et al.
Antibiotics (Basel, Switzerland)
|
November 27, 2021
Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections
Gianluca Morroni, Raffaela Bressan, Simona Fioriti, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 8, 2025
Fluoroquinolones and Biofilm: A Narrative Review
Nicholas Geremia, Federico Giovagnorio, Agnese Colpani, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|
February 14, 2025
Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based study
Salvatore Rotundo, Salvatore Nisticò, Helen Linda Morrone, et al.
International Journal of Antimicrobial Agents
|
May 19, 2021
Zidovudine in synergistic combination with fosfomycin: an in vitro and in vivo evaluation against multidrug-resistant Enterobacterales
Roberta Maria Antonello, Stefano Di Bella, Jonathan Betts, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 27, 2026
Cefepime and New Cefepime/Beta-Lactamase Inhibitor Combination for the Treatment of Gram-Negative Bacteria: Chemical Structure and Mechanism of Action, Microbiological Target, Clinical Use and PK/PD Characteristics
Davide Carcione, Gioconda Brigante, Antonella Carducci, et al.
Page
of 7